Video: Clinical Trials, Bladder Cancer, and COVID-19 writer and moderator, Renata, interviews Dr. Terry Friedlander, a genitourinary medical oncologist at the University of California, San Francisco (UCSF) who specializes in bladder and prostate cancers. During their conversation, Dr. Friedlander gives us an overview and shares his perspective of how COVID-19 is impacting people with bladder cancer in San Francisco at UCSF as of April 17, 2020, the date of this interview.

The COVID-19 crisis in the US is a fluid and rapidly changing situation. For more information, see Self-Care in Uncertain Times.

By providing your email address, you are agreeing to our privacy policy. We never sell or share your email address.

This article represents the opinions, thoughts, and experiences of the author; none of this content has been paid for by any advertiser. The team does not recommend or endorse any products or treatments discussed herein. Learn more about how we maintain editorial integrity here.

Join the conversation

or create an account to comment.